Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial-Reference-Cited by-同舟云学术

Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial

Published:2022-01-14 Issue:3 Volume:49 Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Guzman‑Esquivel Jose¹,Galvan‑Salazar Hector²,Guzman‑Solorzano Hannah²,Cuevas‑Velazquez Andrea²,Guzman‑Solorzano Jose²,Mokay‑Ramirez Karen²,Paz‑Michel Brenda²,Murillo‑Zamora Efren¹,Delgado‑Enciso Josuel³,Melnikov Valery¹,Delgado‑Enciso Osiris²,Rodriguez‑Sanchez Iram⁴,Martinez‑Fierro Margarita⁵,Rojas‑Larios Fabian²,Walle‑Guillen Mireya²,Cardenas‑Aguilar Citlaly²,Beas‑Guzman Oscar²,Chaviano‑Conesa Daniel²,Garcia‑Garcia Hossana¹,Delgado‑Enciso Ivan²

Affiliation:

1. Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28984, Mexico

2. Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico

3. Department of Research, Foundation for Cancer Ethics, Education and Research of the Cancerology State Institute, Colima 28085, Mexico

4. Laboratory of Molecular and Structural Physiology, School of Biological Sciences, Universidad Autónoma de Nuevo León, San Nicolas de los Garza, Nuevo León 66455, Mexico

5. Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Reference37 articles.

1. The coronavirus disease (COVID-19) challenge in Mexico: A critical and forced reflection as individuals and society;Caldera-Villalobos;Front Public Health,2020

2. Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis;Alene;PLoS One,2021

3. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: Summary of a report of 72314 cases from the Chinese center for disease control and prevention;Wu;JAMA,2020

4. Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial;Delgado-Enciso;Exp Ther Med,2021

5. COVID-19 and immune-mediated inflammatory diseases: Effect of disease and treatment on COVID-19 outcomes and vaccine responses;Fagni;Lancet Rheumatol,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Common Anti-Inflammatories on Adenovirus Entry and Their Physicochemical Properties: An In-Depth Study Using Cellular and Animal Models;Microbiology Research;2024-08-19

2. NSAID: Current limits to prescription;Joint Bone Spine;2024-07

3. Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections;Viruses;2024-04-22

4. A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID‐19 patients;Journal of Medical Virology;2024-03

5. Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique;Journal of Cancer Research and Clinical Oncology;2023-11-20